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OBJECTIVE—To determine the distinguishing characteristicsof women whoreport stopping
insulinrestrictionat11yearsoffollow-upfromthosecontinuingtoendorseinsulinrestrictionas
well as those characteristics differing in patients who continue to use insulin appropriately from
new insulin restrictors.
RESEARCH DESIGN AND METHODS—This is an 11-year follow-up study of 207
women with type 1 diabetes. Insulin restriction, diabetes self-care behaviors, diabetes-speciﬁc
distress, and psychiatric and eating disorder symptoms were assessed using self-report surveys.
RESULTS—Of the original sample, 57% participated in the follow-up study. Mean age was
446 12 years, diabetes duration was 28 6 11 years, and A1C was 7.9 6 1.3%. At follow-up, 20
of 60 baseline insulin restrictors had stopped restriction. Women who stopped reported im-
proveddiabetesself-careanddistress,fewerproblemswithdiabetesself-management,andlower
levels of psychologic distress and eating disorder symptoms. Logistic regression indicated that
lowerlevelsoffearofweightgainwithimprovedbloodglucoseandfewerproblemswithdiabetes
self-management predicted stopping restriction. At follow-up, 34 women (23%) reported new
restriction,andalargerproportionof newinsulinrestrictors,relativeto nonrestrictors,endorsed
fear of weight gain with improved blood glucose.
CONCLUSIONS—Findings indicate that fear of weight gain associated with improved blood
glucose and problems with diabetes self-care are core issues related to both the emergence and
resolution of insulin restriction. Greater attention to these concerns may help treatment teams to
better meet the unique treatment needs of women struggling with insulin restriction.
Diabetes Care 34:545–550, 2011
R
estriction of insulin is a problem
unique to type 1 diabetes: the pa-
tient intentionally takes less insulin
than prescribed,which induces hypergly-
cemia, usually aimed at calorie purging
and weight loss. Insulin restriction places
patients with type 1 diabetes at increased
risk for diabetic ketoacidosis and earlier
onsetandhigherratesoflong-termmedical
complications of diabetes, such as retinop-
athy, nephropathy, and neuropathy, as
well as increased risk of mortality (1–4).
To date, only two published reports
have examined the course of insulin
restriction and associated eating distur-
bances by attempting to identify risk
factors for both the development and
worsening of these problems (5,6). These
reports on the same cohort suggest that
disturbed eating behaviors become more
prevalentandincreaseinsymptomseverity
intoyoungadulthood;however,onlythree
participantsintheirsample(2%ofthetotal
group) reported insulin restriction.
We conducted a follow-up assessment
of a cohort of 207 women with type 1
diabetes, aged 13–60 at baseline, whowere
originally assessed 11 years earlier. Insulin
restriction was reported by 31% of women
assessed in the original cohort and was as-
sociated with poorer diabetes self-care,
heightened diabetes-speciﬁc distress, as
well as psychologic distress, fear of hypo-
glycemia, and fear that improved glycemic
control would result in weight gain (7). In-
sulinrestrictionwasassociatedwithathree-
fold increased risk of death during the
11-yearfollow-up(3).Tobetterunderstand
the natural course of insulin restriction in
women with type 1 diabetes, as it resolves
andemerges,wesoughttoidentifytheclin-
ical characteristics that changed in those
women who reported no longer engaging
in insulin restriction at follow-up and also
in those women who reported restricting
insulin for the ﬁrst time at follow-up.
RESEARCH DESIGN AND
METHODS
Study design
The study protocol was approved by the
Committee on Human Studies before
participants were contacted at both as-
sessment times. Participants provided
w r i t t e ni n f o r m e dc o n s e n t .
Baseline inclusion criteria for study
participation were female sex, diagnosis
of type 1 diabetes for at least 1 year, aged
between 13 and 60 years, not currently
pregnant, and no severe visual impair-
ment. Participants were attending routine
diabetes clinic appointments at the time
of their baseline assessments.
For the follow-up study, we sent each
participantfromthe originalstudyaletter
explaining the project and later contacted
herbytelephonetodescribetheprojectin
detail and answer questions. We made
several attempts to locate original partic-
ipants who were lost to follow-up. Clinic
records were searched for possible con-
tact information, and we attempted to
mail information to all addresses and
emergency contacts when listed. We
also searched the National Death Index
to identify and conﬁrm participants who
diedduring thefollow-upperiod.Finally,
we used Internet search engines and a
private search agency to help locate par-
ticipants’ most up-to-date addresses.
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ORIGINAL ARTICLEParticipants
The original participant sample consisted
of 390 women with type 1 diabetes. Of
these, 26 were known to have died, 49
declined to enroll in the follow-up study,
and 108 were lost to follow-up. Thus, the
follow-up sample consisted of 207
women, which represents 57% of the
living cohort. All subsequently described
data analyses refer to the current study
cohort of 207 women, unless described
otherwise. At follow-up, mean age was
44 6 12 years and mean diabetes dura-
tion was 28 6 11 years. Mean BMI was
25 6 5k g / m
2, and mean A1C was 7.9 6
1.3%.
Women who participated in the
follow-up study and those who declined
participation or who were lost to follow-
up did not differ with respect to insulin
restriction status, age, diabetes duration,
A1C, BMI, diabetes complications, or any
of the survey measures administered at
baseline. Baseline characteristics of par-
ticipants who died are described else-
where (3).
Demographic and clinical
information
We gathered demographic and clinical
informationbyrecordabstractionatbase-
line, including age, diabetes duration,
BMI, and presence of diabetes complica-
tions. Baseline laboratory data used HbA1
assays rather than the current A1C stan-
dard. All HbA1 laboratory results were
converted to A1C using a formula devel-
opedthroughcomparativetestingonpaired
samples: A1C = (HbA1 2 0.19)/1.21 (8).
At follow-up, we completed record
abstractions on participants who were
still receiving their care at the clinic.
Thosenolonger beingtreatedattheclinic
received a brief record review form to
be completed by their health care team.
Data gathered using both methods in-
cluded the most recent A1C and BMI
assessmentsandthepresenceofdiabetes
complications.
Psychosocial assessment
We used responses to the screening state-
ment, “I take less insulin than I should,” to
determine insulin restriction status in this
cohort.Responseswereona6-pointLikert
scale ranging from “never,”“ rarely,”
“sometimes,”“ often,”“ usually,” to “al-
ways.” We decided on the following def-
inition of insulin restriction, because we
believed that social desirability pressures
could inﬂuence women to underreport in-
sulin restriction as a symptom, particularly
as part of research being done in a spe-
cialty diabetes center. This decision is
described further in a prior article (3).
We used their responses at baseline to
categorize women as insulin restrictors
if they reported any form of restriction
from,“rarely” to“always.” Theywerecat-
egorized as appropriate insulin users if
theyendorsed“never.” Weusedasimilar
approach to classify participants into
four categories according to their re-
sponses to the same screening question
at follow-up:
Those who did not endorse insulin
restriction at baseline and continued not
to endorse insulin restriction at follow-up
were categorized as “never restricted.”
Those who did not endorse insulin
restriction at baseline but did endorse
insulin restriction at follow-up were cat-
egorized as “new insulin restriction.”
Those who endorsed insulin restric-
tion at baseline and continued to endorse
insulin restriction at follow-up were cat-
egorized as “continued insulin restric-
tion.”
Those who endorsed insulin re-
striction at baseline but no longer en-
dorsed insulin restriction at follow-up
were categorized as “stopped insulin
restriction.”
Participants completed the same bat-
tery ofpsychosocialsurveysatbaselineand
follow-up; however, they completed a re-
vised version of the Self-Care Inventory
(SCI-R) at follow-up. For all surveys de-
scribed subsequently, higher scores indi-
cate higher levels of the variable being
measured.
The SCI-R (9,10) measures self-
reportedfrequencyofadherencetodiabetes
self-care tasks, including blood glucose
monitoring frequency and insulin ad-
ministration.
The Problem Areas in Diabetes (PAID)
survey (11,12) is a 20-item Problem ques-
tionnairethatassessesabroadrangeoffeel-
ings related to living with diabetes.
The Hypoglycemia Fear Survey–Worry
Subscale(13)isa17-itemquestionnairethat
assesses level of worry about hypoglycemia.
The Brief Symptom Inventory (BSI)
(14) is a 53-item questionnaire that mea-
sures psychiatric symptoms. Here, we ex-
amined scores on the depression and
anxiety subscales as well as the global se-
verity index.
Bulimia Test-Revised (15) is a 36-item
questionnaire to measure attitudes and be-
haviors central to eating disorders, such as
weight and shape preoccupation, fear of
weightgain,restrictiveeating,bingeeating,
and purging behaviors. This measure has
been used in previous diabetes research
(16).
We measured self-reported diabetes-
speciﬁc eating and weight concerns on a
5-point and 6-point Likert scale survey
created speciﬁcally for the original proj-
ect. Participants rated how much their
weight or body shape inﬂuenced how
they felt about themselves as people (“not
at all inﬂuenced,”“ slightly inﬂuenced,”
“somewhat inﬂuenced,”“ moderately
inﬂuenced,”“ very much inﬂuenced”). At-
titudes toward diabetes treatment and its
relationship to weight were assessed us-
ing answers to two statements: “Ia m
afraid that getting my blood sugars in
good control will cause me to gain
weight” (“never,”“ rarely,”“ sometimes,”
“often,”“ usually,”“ always,” for some
analyses “never” was coded as “no” and
“rarely” through “always” were coded as
“yes”). “Taking insulin makes me gain
weight” (“no” or “yes”). This survey also
included four items evaluating problems
with diabetes self-management, such as
poor blood glucose control, not monitor-
ing blood glucose frequently, not taking
medicationsattherecommendtimes,and
notfollowingnutritionorexerciserecom-
mendations.
Statistical analyses
Data are presented as means 6 SDs for
continuous variables and percentages for
categoric variables. We used Wilcoxon
two-sample rank sum tests to compare
differences in means. The x
2 and Fisher
exact tests were used to compare propor-
tions in categoric variables between 1)
women who continued to report insulin
restriction and those whostoppedinsulin
restriction at follow-up and 2)w o m e n
who never reported insulin restriction
and those with new insulin restriction at
follow-up. Paired t tests were used to
compare mean differences in change
scores within the four groups described
previously. Because of multiple analyses,
we used a conservative P value of , 0.01
to indicate statistical signiﬁcance and P
values between 0.01 and 0.05 to indicate
statistical trends for group comparisons.
Finally, we used logistic regression anal-
yses to predict insulin restriction status
at follow-up. Statistical analyses were
performed using SAS 9.2 software (SAS
Institute, Cary, NC).
RESULTS—A total of 60 women en-
dorsed insulin restriction at baseline; of
these, 40 continued insulin restriction at
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Insulin restriction in type 1 diabetesfollow-up, and 20 stopped insulin re-
striction.Ofthosewomenwhocontinued
insulin restriction at follow-up, 55% re-
ported doing so “sometimes,”“ often,” or
“usually.”Atbaseline,147womenreported
appropriate insulin use, and at follow-
up, 113 continued to report appropriate
insulin use; however, 34 women en-
dorsed new insulin restriction, of whom
53% reported the behavior occurred
“sometimes” or “often.”
Distinguishing characteristics of
women who no longer reported
insulin restriction
Table 1 reports comparisons between
womenwhocontinuedtoendorseinsulin
restriction and those who stopped insulin
restriction at follow-up. The groups did
not differ at baseline. At follow-up, how-
ever, women who no longer endorsed
insulin restriction reported less diabetes-
speciﬁc distress (P , 0.01), fewer prob-
lems with diabetes self-management (P ,
0.001), higher levels of diabetes self-care
(P,0.01),lowerlevelsofoverallpsycho-
logic distress (P , 0.01), and lower levels
of eating disorder symptoms (P , 0.01).
Women who stopped insulin restriction
did not differ from women who contin-
ued to restrict with regard to the number
who reported commercial weight loss at-
tempts in their lifetimes (35 vs. 33%, P =
0.85).However, the twogroupsdid differ
in diabetes and weight-related attitudes.
Speciﬁcally, relative to women who con-
tinued insulin restriction, a smaller per-
centage of those who stopped restricting
endorsed the statement that they were
“afraid that getting my blood sugars in
goodcontrolwillcausemetogainweight”
(55 vs. 82%, P , 0.01). Women who
stopped insulin restriction were also less
likely to agree with the statement, “taking
insulin makes me gain weight” (20 vs.
58%, P , 0.01).
Prescribed diabetes management
plans did not differ between groups.
Both reported an average of two pre-
scribed insulin injections per day at base-
line and an average of three at follow-up.
Those women who stopped insulin re-
striction reported an average of four di-
abetes medical appointments per year at
baseline compared with six at baseline in
the other group, but this was not statis-
tically signiﬁcant. The two groups also
did not differ on this variable at follow-
up, with a respective average of 4.8 and
four diabetes medical appointments per
year at follow-up. No additional differ-
ences were found between diabetes treat-
ment plans at follow-up: 27% reported
insulin pump use, 58% reported using
carbohydrate counting, and 28% reported
using the exchange method for meal
planning. No differences were noted in
the reported average number of mild
hypoglycemic events in the past month,
with 6.7 reported by those who stopped
insulin restriction and 7.1 reported by
those who continued to restrict. At base-
line and follow-up, the two groups did
not have different rates of women report-
ing one or more diabetes complications
(47% at baseline and 63% at follow-up).
Within-group analyses of women
who stopped insulin restriction showed
that they also reported improvements in
diabetes self-care (P , 0.01), diabetes-
speciﬁcd i s t r e s s( P , 0.001), and prob-
lems with diabetes self-management (P ,
0.001) at follow-up. Within-group analy-
ses of continued insulin restrictors also
showed lower average A1C (P , 0.01);
however, their average BMI increased by
2.3 points (P , 0.001), whereas the aver-
age BMI of women who stopped restrict-
ing insulin remained stable at follow-up.
Between-group analyses showed that
problems with diabetes self-management
improved more among those who stop-
ped insulin restriction than those who
continued (20.9 vs. 0.2, P , 0.001).
After we controlled for age and
follow-up BMI in a logistic regression
model,fewerproblemswithdiabetesself-
managementreportedatfollow-up(odds
ratio [OR] 0.59 for each 10-point in-
crease, P , 0.03) and less fear of weight
gain associated with healthier blood glu-
cose ranges reported at follow-up (OR
0.4,P , 0.02)predictedstoppinginsulin
restriction. The overall model was 86%
concordant.
Distinguishing characteristics of
women newly reporting insulin
restriction
Table 2 summarizes comparisons be-
tween women who never endorsed insu-
lin restriction and those who reported
new insulin restriction. These two groups
did not differ at baseline. At follow-up,
Table 1—Characteristics of women who continue to endorse insulin restriction and those who stopped insulin restriction at follow-up
Continued insulin restriction (n = 40) Stopped insulin restriction (n = 20)
Characteristic Baseline Follow-up Mean change Baseline Follow-up* Mean change
Diabetes duration (years) 29.9 6 8.9 —— 28.9 6 10.1 ——
Age (years) 30.0 6 9 —— 32.5 6 12.8 ——
Married 54 63 — 54 65 —
A1C (%) 9.2 6 1.7 8.3 6 1.0 20.9† 9.4 6 2.2 7.9 6 1.2 21.5‡
Years of education 14.8 6 2 15.4 6 1.6 14 6 2 14.5 6 1.7‡
BMI (kg/m
2) 23.2 6 3 25.5 6 4.8 2.3§ 22.7 6 2.3 23 6 2.5 0.4
Problem Areas in Diabetes score 51 6 20 43.6 6 20.9 27.9† 44.9 6 18.4 25.7 6 22† 219.3§
Diabetes self-management problems 52 6 21 47 6 27.3 24.6 54.7 6 26 18.3 6 14.3§ 236.6§
Fear of hypoglycemia 34 6 20.2 33.5 6 18.8 21.3 32.4 6 20.4 30.2 6 15.9 23.2
Self-Care Inventory score 51 6 18 53.7 6 12.3 1.4 49.6 6 18.6 66.8 6 14.9† 16.7†
Brief Symptom Inventory score
Depression 59.8 6 10.5 59.3 6 11.3 21.3 60 6 8.9 54 6 10.7 27.2‡
Anxiety 58.9 6 9.7 58.6 6 10.9 20.9 58 6 9.2 52.4 6 10.7‡ 25.7
Global severity 60.3 6 11 61.1 6 10.2 0.5 59.5 6 9.8 52.6 6 9.8† 26.9
Bulimia Test-Revised 63.6 6 23.3 64.6 6 23.7 0.9 62.6 6 28 46.2 6 16.9† 216.4‡
Continuousdataareshownasmean6SD,andcategoricdataaspercentage.*Pvaluesymbolsinthiscolumnindicatedifferencesbetweenmeansforthetwogroupsat
follow-up. †P , 0.01; ‡P , 0.05; §P , 0.001.
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Goebel-Fabbri and Associatesmore new insulin restrictors than those
never restricting endorsed the statement
that they were “afraid that getting my
blood sugars in good control will cause
me to gain weight” (62 vs. 36%, P ,
0.01). Only 23% of women who never
reported insulin restriction versus 50%
of women who endorsed new reported
r e s t r i c t i o nr e p o r t e dc o m m e r c i a lw e i g h t
loss attempts in theirlifetimes (P ,0.01).
Prescribed diabetes management
plans did not differ between groups.
Both reported an average of two pre-
scribed insulin injections per day at base-
line and an average of three at follow-up.
They also reported an average of 3.5
diabetes medical appointments per year
at baseline and four at follow-up. In
addition at follow-up, 36% reported
insulin pump use, 60% reported using
carbohydrate counting, and 30% reported
using the exchange method for meal
planning. Despite this lack of differences
in prescribed diabetes management
plans, there was a difference at follow-
up in the reported average number of
mild hypoglycemic events in the past
month, with 8.4 6 7.9 reported by those
who stopped insulin restriction and
5.6 6 5.6 reported by those who contin-
uedtorestrict(P, 0.05).Atbaselineand
follow-up, the rates of women reporting
oneormorediabetescomplications(36%
at baseline and 64% at follow-up) were
similar in the two groups.
Within-group analyses of women
newly reporting insulin restriction
showedthatthesewomenhadanincrease
in BMI (P , 0.01) and also reported an
increase in fear that improved glycemia
would result in weight gain (0.7 vs. 0.2,
P , 0.001). Within-group analyses of
women who never reported insulin re-
striction also showed increased BMI
(P , 0.001), improvements in diabetes-
speciﬁcd i s t r e s s( P , 0.001), improved
anxiety (P , 0.01), and fewer reported
problems with diabetes self-management
(P , 0.001).
Between-group analyses showed that
women whonever reportedinsulin restric-
tionshowedimprovementsinself-reported
problems with diabetes self-management
(P , 0.01). Women endorsing new insu-
lin restriction indicated more fear of
weight gain associated with healthier
blood glucose ranges relative to women
who never endorsed insulin restriction
who showed little change (P , 0.01).
After controlling for age and follow-
up BMI in a logistic regression model,
problems with diabetes self-management
predicted new insulin restriction (OR
1.5 for each 10-point increase, P ,
0.001).Theoverallmodelwas74%con-
cordant.
CONCLUSIONS—Toourknowledge,
thisstudyistheﬁrsttoaddressthenatural
course of insulin restriction by examin-
ing factors associated with both its resolu-
tion and new emergence over time. These
ﬁndings may help inform current treat-
ment of patients struggling with insulin
restriction by providing evidence that the
behaviors can improve and by identifying
characteristics associated with improve-
ment.
Logistic regression analyses revealed
that fear of weight gain associated with
improved blood glucose and problems
with diabetes self-care are core issues
related to both the emergence and res-
olution of insulin restriction. Women
who stopped insulin restriction and those
who continued the behavior showed no
between-group differences at baseline;
however, the two groups did differ at
follow-up. Notably, women who stopped
restricting reported a higher frequency of
diabetes self-care behaviors and lower
levels of diabetes-speciﬁcd i s t r e s sa n d
problems with self-management than
women still restricting insulin at follow-
up. Women who stopped also endorsed
fewer eating disorder symptoms and
lower levels of overall psychologic dis-
tress. More importantly, among women
who stopped insulin restriction, a smaller
proportion continued to endorse fears
that improving blood glucose control or
even taking insulin would cause weight
gain.
Although it did not reach statistical
signiﬁcance (P , 0.01), the mean A1C
improved in women who stopped insulin
restriction from 9.4% at baseline to 7.9%
at follow-up, and their BMI was main-
tained during the same period. Paradoxi-
cally, mean AIC levels also improved in
women who continued to restrict insulin,
from 9.2 to 8.3%; however, their BMIs
increased from 23.2 to 25.5 kg/m
2.A 1 C
improvements in both groups may reﬂect
Table 2—Characteristics of women who never endorsed insulin restriction and those who newly endorse it at follow-up
Never restricted (n = 113) New insulin restriction (n =3 4 )
Characteristic Baseline Follow-up Mean change Baseline* Follow-up† Mean change
Diabetes duration (years) 29 6 12.7 —— 24 6 9 ——
Age (years) 35 6 13 —— 32 6 11.4 ——
Married 54 80 — 54 82 —
A1C (%) 8.2 6 1.4 7.7 6 1.3 20.4‡ 8.2 6 1.5 8.4 6 1.4‡ 0.2
Years of education 14 6 2.6 15.3 6 2.1 14.6 6 2.5 15.4 6 1.5
BMI (kg/m
2) 23.5 6 3.5 25.4 6 5.1 1.9§ 23.2 6 2.4 24.9 6 3.4 1.8‡
Problem Areas in Diabetes score 24.3 6 17 18.8 6 17 25.6§ 26.2 6 17 24.7 6 17‡ 21.8
Diabetes self-management problems 25 6 21 17.8 6 16.9 27.3§ 28.2 6 21 32.7 6 23.5§ 4.6
Fear of hypoglycemia 25 6 17 24.3 6 20.6 20.7 25 6 14.6 24.8 6 16.9 20.8
Self-Care Inventory score 72.2 6 13.4 70 6 12.8 22.1 66.5 6 12.2‡ 60.2 6 17.8| 25.2‡
Brief Symptom Inventory score
Depression 53.4 6 9.9 51.4 6 10.1 22.3‡ 53.6 6 9.8 52.8 6 9.6 0.7
Anxiety 53.4 6 10.3 50.3 6 10 23.2| 53.4 6 9.5 53.2 6 9.3 0.7
Global severity 54.3 6 10.3 53 6 10.1 21.6 53.9 6 10.9 54.8 6 9.2 0.7
Bulimia Test-Revised score 43.9 6 14.8 43.7 6 14 20.4 46.9 6 16.7 48.4 6 17 0.5
Continuous data are presented as mean 6 SD, and categoric data as percentage. *P value symbols in this column indicate differences between means for the two
groups at baseline. †P value symbols in this column indicate differences between means for the two groups at follow-up. ‡P , 0.05; §P , 0.001; |P , 0.01.
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Insulin restriction in type 1 diabetestheemphasisclinicians are placingon im-
proved glycemic control since the publi-
cation of the Diabetes Control and
Complications Trial results (17).
At follow-up, new insulin restrictors
endorsed higher levels of problems with
diabetes self-management and lower lev-
els of overall diabetes self-care. More new
insulin restrictors acknowledged using
their weight as a means of judging their
self-worth and also endorsed fears that
improving blood glucose control would
result in weight gain. Despite insulin
restriction, new insulin restrictors had
an increase in BMI between baseline and
follow-up. In fact, both groups of insulin
restrictors—those who continued and
those newly restricting—endorsed fear
of weight gain associated with improved
blood glucose; however, both groups
actuallyexperiencedweightgaindespite
insulin restriction.
Increases in BMI in the context of
body image concerns may reinforce a
cycle of negative diabetes self-care behav-
iors that will, for some women, include
insulin restriction and disordered eating.
Unlike the women who never restricted
insulin, whose BMIs increased over time,
those women who stopped insulin re-
striction did not increase their average
BMIbetweenbaselineandfollow-up.This
may be due to a relative lack of weight
concern among those who never restricted
insulin as opposed to continued, albeit
signiﬁcantly healthier, weight concerns
among those women who stopped insulin
restriction.
This interpretation may be supported
by our data showing that more insulin
restrictors endorse lifetime participation
in commercial weight loss programs than
those women who do not report insulin
restriction. Other studies report higher
BMI as a child or teen as a risk factor for
developingeatingdisorderbehaviors(5,6);
however, we did not ﬁnd this in the
adults who newly restricted at follow-
up. In fact, baseline BMI did not differ
among the four groups in our study. Per-
hapsbyolderadolescencethroughadult-
hood, higher BMI is no longer observed
as a risk factor because eating disorder
behaviors have already begun by this
point in women’sd e v e l o p m e n t .
This study conﬁrms earlier research
indicating that body weight and shape
concerns are strongly related to insulin
restriction women with type 1 diabetes
(18,19). Indeed, clear differences
emerged between women who stopped
insulin restriction and those who newly
restricted orcontinued to restrict; namely,
those reporting restriction identiﬁed
weight as an important marker of self-
worth and reported fears about insulin
treatment and improvements in glycemia
causing weight gain. Women who stop-
ped insulin restriction were less likely to
endorse these types of weight and shape
concerns relative to women who were
newly restricting insulin or continuing
to restrict.
These ﬁndings highlight the impor-
tance of diabetes clinicians taking wom-
en’sw e i g h tc o n c e r n ss e r i o u s l ya n d
addressing them as part of their overall
diabetes treatment plans. Diabetes treat-
ment teams can actively engage women
who they believemaybenewlystruggling
with adherence problems and insulin re-
striction in open communication about
their weight and shape concerns as they
relate to diabetes adherence and insulin
use. Our data indicate that women who
restrictedinsulinexperiencedincreasesin
BMI, while those who stopped restricting
did not. These ﬁndings could be used by
diabetes clinicians as a potential tool for
psychoeducation to prevent or help
women to stop insulin restriction. We
strongly recommend closer follow-up
with nurse educators and dietitians and
referrals to mental health specialists with
expertise in eating disorders when needed.
Unfortunately, our research did not evalu-
ate potential differences in diabetes self-
care behaviors as they might pertain to
the nature of the patient-diabetes team
relationships and continuity of care ver-
sus transitioning between multiple care
providers. We regret that our data did
not allow us to analyze the inﬂuence of
these factors as they may relate to the
emergence or improvement of insulin re-
striction over time.
Our ﬁndings are limited by low
power due to small group sizes and un-
balanced numbers in each of the four
comparison groups and through the use
of a cross-sectional design. In addition,
our data are based on self-report assess-
ments and did not include the opportu-
nity for interviews to more formally
establish active insulin restriction. For
this reason, we were also unable to ask
womenabouttheirownunderstandingof
how and why their insulin use changed
over time. It may be that by limiting our
evaluations to questionnaire assessments,
we have missed important and as yet un-
recognized variables.
Thus, we see a need for prospective,
longitudinal research of this issue that
includes frequent assessments through-
outsuchastudy’sduration.Thereisalsoa
need for qualitative research involving fo-
cus groups or open-ended interview
questions, or both, to gain a better under-
standing of how women themselves un-
derstand what led them to stop insulin
restriction and also what led them to start
the behavior. Given the important
changes in attitudes about diabetes treat-
ment, insulin use, and its relationship to
weight, we also see an additional need for
future research evaluating intervention
strategies that directly address these
core attitudes among women with type 1
diabetes who restrict insulin. Such strat-
egies could include cognitive restructur-
ing of fears that appropriate insulin use
a n di m p r o v e dg l y c e m i al e a dt ow e i g h t
gain and of the importance that these
womenplaceonweightasamarkeroftheir
self-worth. Designing and empirically vali-
dating such treatments is critical for this
high-risk population.
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